NewsBenzinga프리놈, 두 가지 독립적으로 검증된 적응증별 검사로 단일 혈액 채취를 통해 폐암 및 대장암 검진이 가능한 ‘심플스크린 런’ 출시 프리놈, 두 가지 독립적으로 검증된 적응증별 검사로 단일 혈액 채취를 통해 폐암 및 대장암 검진이 가능한 ‘심플스크린 런’ 출시 Benzinga 2026.10.20 12:34 (GMT+0) Open on Benzinga Other news EXCLUSIVE: Ryan Detrick Isn’t Worried About Midterm Election Outcome – ‘Focus on the Fundamentals’ DA Davidson Maintains Neutral on RideNow Group, Lowers Price Target to $5 Nvidia China Trouble Could Spill Over to These AI Chip Stocks Wall Street Looks Beyond US Stocks: Morgan Stanley’s Europe Call Puts These ETFs on the Radar Fed's Hammack Says Businesses Are Passing On More Price Increases; Says Job Market Has Been Largely In Balance, But Is Not Dynamic Citigroup Maintains Buy on Nebius Group, Lowers Price Target to $215
Fed's Hammack Says Businesses Are Passing On More Price Increases; Says Job Market Has Been Largely In Balance, But Is Not Dynamic